1. Faruqi & Faruqi investigates claims against Semler Scientific for investor losses. 2. Semler Scientific's stock fell over 9% after revealing DOJ settlement talks ceased. 3. The company faces potential civil lawsuit under the False Claims Act. 4. Investors are encouraged to discuss legal rights with Faruqi & Faruqi.
The stock decline of over 9% indicates strong negative market sentiment driven by legal uncertainties and potential financial liabilities, particularly with a False Claims Act lawsuit looming. A similar historical example can be seen with other firms facing DOJ claims, where stock prices typically drop significantly during litigation phases.
The investigation into Semler Scientific implies significant risks for investors, particularly given the stock's reaction and previous examples where similar situations led to steep declines in value.
The immediate market reaction indicates short-term price pressure as investors assess risks. Historically, stocks facing litigation see a rapid response, typically stabilizing only after clearer resolutions emerge.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
If you suffered significant losses in Semler Scientific stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Semler Scientific, Inc. ("Semler Scientific" or the "Company") (NASDAQ:SMLR).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
After trading hours on February 28, 2025, Semler Scientific filed with the SEC its 2024 annual report on Form 10-K. The annual report disclosed that on February 11, 2025, Semler Scientific "began initial settlement discussions with DOJ [(the United States Department of Justice)], but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages. [Semler Scientific] does not believe the amount of loss can be reasonably estimated."
On this news, Semler Scientific's stock fell over 9% on the next trading day.
To learn more about the Semler Scientific investigation, go to www.faruqilaw.com/SMLR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250909756701/en/
Faruqi & Faruqi, LLP
Josh Wilson
877-247-4292 or 212-983-9330 (Ext. 1310)